Radiopharmaceuticals have emerged as a rapidly evolving field at the interface of medicinal chemistry, molecular imaging, and targeted therapy. Progress in radiopharmaceutical development and translational imaging has rapidly expanded the range of diagnostic and therapeutic tools available for cancer, neurological, cardiovascular, and inflammatory diseases.